Skip to content
  • Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank and/or databank
  • Documents
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
  • Contact & Info
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Meeting dates 2023
  • English
    • Dutch
Menu
  • Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank and/or databank
  • Documents
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
  • Contact & Info
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Meeting dates 2023
  • English
    • Dutch
Search
Close

Recruiting and informing the potential subject.

The METc prefers that the patient, as a potential subject in a clinical trial, is approached by the treating physician . The physician discusses general information about the clinical trial and asks permission to give the patients’ contact details to the investigator. 

Print or export to pdf
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact

POWERED BY Wild Sea 2020